Autophagy Assassins: Exosome-Mediated Inhibition of Calcineurin-TFEB Signaling
CSEF · 2026 Medicine & Physiology (Senior Division)
Overview
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with a survival rate of approximately 13%. 90% of PDAC tumors possess KRAS mutations, which drive tumor hyperproliferation, promoting reliance on autophagy for tumor survival. The transcription factor EB (TFEB), a master regulator of lysosomal biogenesis, is tightly related to autophagy. More specifically, TFEB regulates the CLEAR gene network, controlling lysosome biogenesis and autophagy. In low-nutrient environments, TFEB localization is regulated by the phosphatase calcineurin, which dephosphorylates TFEB and causes its nuclear localization, upregulating the CLEAR network. Disruption of this dephosphorylation and localization of TFEB is a promising target to disrupt autophagy and subsequent tumor survival in PDAC. To disrupt calcineurin-TFEB signaling, this study investigated whether exosomal delivery of an NFATc1-derived peptide containing the calcineurin-binding LxVP motif would competitively bind calcineurin, prevent TFEB nuclear localization, and disrupt autophagy signaling in PDAC cells. In-silico docking simulations using CABS-dock were performed to confirm peptide binding to the calcineurin LxVP pocket. Exosomes were loaded with NFATc1-YLAVP peptide using saponin-mediated permeabilization, and encapsulation was validated using a protease protection assay with Proteinase K ± saponin through fluorescence signals, giving a 40.3% loading efficiency. PANC-1 cells were seeded, treated with varying peptide concentrations loaded into the exosomes, and starved with HBSS to induce autophagy. Immunofluorescence microscopy was used to quantify TFEB nuclear localization, and data analysis yielded a 49.7% reduction. These results demonstrate a successful exosome-mediated peptide delivery strategy capable of inhibiting calcineurin-TFEB signaling and reducing autophagy activity in PDAC cells.
Competition history
- CSEF 2026
Related projects
ISEF · 2026
Next Generation Cancer Therapeutics: Peptide Binder Impairing Oncogenic KRAS Signalling by Inhibition of KRAS–PDEd Interaction
ISEF · 2025
Decoding PDAC: A scRNA-seq Omics Analysis to Unveil and Inhibit Key Protein Using a Novel in-silico, Structure-Based Drug Design Pipeline
ISEF · 2025
Lipid Facilitated PDAC Stroma Transmission: Overcoming the Desmoplastic Stroma Through Advanced Drug Delivery, in vivo
CSEF · 2026
Exosome-Packed Phenyl Boronate, a Redox Scavenger as an Effective Sensitizer for Immunotherapy in Cervical Cancer
ISEF · 2022
Altering Metabolic Pathways To Override Drug Resistance in Cancer
ISEF · 2025
Lipid-Based Codelivery of Doxorubicin and siRNA PD-L1, as a Multi-function Chemo-Immunotherapy, Selective to Pancreatic Cancer via Its MUC1 Overexpression
JSHS · 2025
Lipid-based Codelivery of Doxorubicin and siRNA PD -L1, as a Multi-function Chemo - immunotherapy, Selective to PDAC via its MUC1 Overexpression
ISEF · 2025
The Development of a Biomarker for Pancreatic Ductal Adenocarcinoma Detection: Investigating Human Antigen R's Expression and Translocation in Response to Cytokine Regulator (cyclic GAMP) and Cytokine (Interferon Gamma) Using Immunocytofluorescence Staining
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects